New research: GLP-1 drugs are safe and effective in obese children without diabetes

New research presented at the International Congress on Obesity (ICO2026) held in Mexico reveals that GLP-1 receptor agonists can be used for weight…

The study is considered a promising step in the treatment of pediatric obesity, documenting that this group is both safe and effective.